Regeneron Pharmaceuticals

Filed a patent for "bispecific antigen-binding molecules and uses thereof" on Fri, August 18, 2023

Filed a patent for "bispecific antigen-binding molecules and uses thereof" on Fri, August 25, 2023

Filed a patent for "cancer therapies targeting vista" on Wed, August 2, 2023

Filed a patent for "cancer therapies targeting vista" on Fri, October 27, 2023

Filed a patent for "methods of treating multiple myeloma with bispecific anti-bcma x anti-cd3 antibodies" on Thu, February 13, 2025

Filed a patent for "botulinum neurotoxin-specific capture agents, compositions, and methods of using and making" on Thu, January 23, 2025

Filed a patent for "stabilized formulations containing anti-bcma x anti-cd3 bispecific antibodies" on Fri, July 7, 2023

Filed a patent for "anti-human cacng1 antibody-drug conjugates and uses thereof" on Mon, July 10, 2023

Filed a patent for "bispecific pd-l1x4-1bb antibodies and methods of use thereof" on Mon, July 10, 2023

Filed a patent for "bispecific pd-l1xcd28 antibodies and methods of use thereof" on Mon, July 10, 2023

Filed a patent for "stabilized formulations containing anti-bcma x anti-cd3 bispecific antibodies" on Thu, December 21, 2023

Filed a patent for "bispecific pd-l1x4-1bb antibodies and methods of use thereof" on Fri, May 10, 2024

Filed a patent for "bispecific pd-l1xcd28 antibodies and methods of use thereof" on Fri, May 10, 2024

Filed a patent for "retainer adapter assembly" on Thu, March 7, 2024

Filed a patent for "circularized antibody molecules" on Sun, June 11, 2023

Filed a patent for "tmprss3 gene therapy for hearing disorders" on Thu, June 15, 2023

Filed a patent for "cd40 x cd40 bispecific antigen-binding molecules and uses thereof" on Fri, June 16, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Fri, June 23, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Mon, June 26, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Wed, August 9, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Mon, September 25, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Mon, October 30, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Mon, November 20, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Thu, November 30, 2023

Filed a patent for "extended, high dose vegf antagonist regimens for treatment of angiogenic eye disorders" on Tue, December 5, 2023